These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2417428)

  • 1. [Determination of angiotensin converting enzyme in prostate diseases].
    Van Camp K; Van Sande M; Neels H
    Verh K Acad Geneeskd Belg; 1985; 47(4):287-302. PubMed ID: 2417428
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer.
    Ueda T; Ichikawa T; Tamaru J; Mikata A; Akakura K; Akimoto S; Imai T; Yoshie O; Shiraishi T; Yatani R; Ito H; Shimazaki J
    Am J Pathol; 1996 Nov; 149(5):1435-40. PubMed ID: 8909232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monodispersal and deoxyribonucleic acid analysis of prostatic cell nuclei.
    Goerttler K; Ehemann V; Tschahargane C; Stoehr M
    J Histochem Cytochem; 1977 Jul; 25(7):560-4. PubMed ID: 70447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of prostatic fluid in prostatic pathology.
    Grayhack JT; Lee C
    Prog Clin Biol Res; 1981; 75A():231-46. PubMed ID: 6175976
    [No Abstract]   [Full Text] [Related]  

  • 5. Distribution of angiotensin converting enzyme in human tissues.
    van Sande ME; Scharpé SL; Neels HM; Van Camp KO
    Clin Chim Acta; 1985 Apr; 147(3):255-60. PubMed ID: 2581725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Benign mimickers of prostatic adenocarcinoma: diagnostic features and differential diagnosis].
    Cheng L; Huang W; Li Y; Wang L
    Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):52-8. PubMed ID: 24713255
    [No Abstract]   [Full Text] [Related]  

  • 7. [Expression of kinase insert domain-containing receptor in prostate adenocarcinoma].
    Bai AS; Zeng H; Li X; Wei Q; Li H; Yang YR
    Zhonghua Nan Ke Xue; 2007 Apr; 13(4):324-6. PubMed ID: 17491265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormone study of patients with adenoma and adenocarcinoma of the prostate].
    Burghele T; Apostol N; Ioanid PC
    Acta Urol Belg; 1967 Jul; 35(3):389-400. PubMed ID: 4182042
    [No Abstract]   [Full Text] [Related]  

  • 9. Metallothionein expression in human prostate gland.
    Bataineh ZM; Nusier MK
    Saudi Med J; 2003 Nov; 24(11):1246-9. PubMed ID: 14647563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further observations on the in vitro 65Zn-binding sites of human prostatic tissues.
    Sato CS; Györkey F
    Cancer Res; 1969 Feb; 29(2):399-402. PubMed ID: 4179556
    [No Abstract]   [Full Text] [Related]  

  • 11. Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma.
    Hussein MR; Al-Assiri M; Musalam AO
    Exp Mol Pathol; 2009 Apr; 86(2):108-13. PubMed ID: 19111537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactivity of ubiquitin in human prostate gland.
    Bataineh ZM; Habbal O
    Neuro Endocrinol Lett; 2006 Aug; 27(4):517-22. PubMed ID: 16892003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc in normal and pathological human prostate gland.
    Bataineh ZM; Bani Hani IH; Al-Alami JR
    Saudi Med J; 2002 Feb; 23(2):218-20. PubMed ID: 11938400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of dihydrotestosterone deficit on treatment of prostatic diseases regarding to contemporary methods of prostatic hypertrophy treatments].
    Laszczyńska M; Chorzepa-Nowicka K; Wylot M; Piasecka M; Gaczarzewicz D
    Pol Merkur Lekarski; 2008 Dec; 25(150):528-30. PubMed ID: 19205388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of angiotensin-converting enzyme in the human prostate: pathological expression in benign prostatic hyperplasia.
    Nassis L; Frauman AG; Ohishi M; Zhuo J; Casley DJ; Johnston CI; Fabiani ME
    J Pathol; 2001 Dec; 195(5):571-9. PubMed ID: 11745693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Zinc levels in prostatic fluid of patients with prostate pathologies].
    Gómez Y; Arocha F; Espinoza F; Fernández D; Vásquez A; Granadillo V
    Invest Clin; 2007 Sep; 48(3):287-94. PubMed ID: 17853788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of putrescine, spermine and spermidine in human tissues of prostate and kidney.
    Dunzendorfer U; Russell DH
    Arzneimittelforschung; 1980; 30(10):1801-4. PubMed ID: 6159903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyamine profiles in human pathological prostate tissue.
    van Sande M; Van Camp K; Van Berendonckx J
    Urol Int; 1983; 38(6):368-70. PubMed ID: 6197799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The copper concentration of hyperplastic and cancerous prostates.
    Wiederanders RE; Evans GW
    Invest Urol; 1969 Mar; 6(5):531-3. PubMed ID: 4180465
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer.
    Stefanou D; Batistatou A; Kamina S; Arkoumani E; Papachristou DJ; Agnantis NJ
    In Vivo; 2004; 18(2):155-60. PubMed ID: 15113042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.